Compare GNLX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLX | IH |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 116.0M |
| IPO Year | 2023 | 2020 |
| Metric | GNLX | IH |
|---|---|---|
| Price | $4.36 | $2.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 140.8K | 9.3K |
| Earning Date | 11-05-2025 | 12-29-2025 |
| Dividend Yield | N/A | ★ 3.88% |
| EPS Growth | N/A | ★ 5.85 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $119,261,855.00 |
| Revenue This Year | N/A | $39.02 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $1.55 |
| 52 Week High | $8.54 | $3.60 |
| Indicator | GNLX | IH |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 35.95 |
| Support Level | $4.20 | $2.15 |
| Resistance Level | $4.37 | $2.40 |
| Average True Range (ATR) | 0.25 | 0.13 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 46.90 | 14.63 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.